Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia

Human Immunology

Volumn 76, Issue 6, 2015, Pages 421-426

  Hoh, B P ^a   Umi Shakina, H ^a   Zuraihan, Z ^a   Zaiharina, M Z ^a   Rafidah Hanim, S ^b   Mahiran, M ^c   Nik Khairudin, N Y ^c   Benedict, L H Sim ^d   Masliza, Z ^d   Christopher, K C Lee ^d   Sazaly, A B ^e  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c General Hospital Kota Bharu   (Malaysia)

^d HOSPITAL SUNGAI BULOH   (Malaysia)

^e UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Common variant; CXCL10; CXCL11; CXCR3; Dengue; Genetic association; Vascular permeability

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; CXCL11 CHEMOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENOMIC DNA; CXCL10 PROTEIN, HUMAN; CXCL11 PROTEIN, HUMAN; CXCR3 PROTEIN, HUMAN; LIGAND;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROL; CONTROLLED STUDY; DENGUE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALAYSIA; MALE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; CAPILLARY PERMEABILITY; CASE CONTROL STUDY; DENGUE VIRUS; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ALLELES; CAPILLARY PERMEABILITY; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CHEMOKINE CXCL11; DENGUE; DENGUE VIRUS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LIGANDS; MALAYSIA; MALE; RECEPTORS, CXCR3; SEVERITY OF ILLNESS INDEX;

EID: 84930484077     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2015.03.019     Document Type: Article

References (34)

1. Dengue, Dengue Hemorrhagic Fever and Dengue Shock Syndrome in the Context of the Integrated Management of Childhood Illness 1997, World Health Organization, WHO, Geneva.
2. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control 2009, World Health Organization, WHO, Geneva.
3. Ministry of Health. http://www.moh.gov.my/.
4. Halstead S.B., Rojanasuphot S., Sangkawibha N. Original antigenic sin in dengue. Am. J. Trop Med. Hyg. 1983, 32:154-156.
5. Mongkolsapaya J., Dejnirattisai W., Xu X., et al. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 2003, 9:921-927.
6. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp. Immunol. Microbiol. Infect. Dis. 2007, 30:329-340.
7. Rothman A.L. Dengue: defining protective versus pathologic immunity. J. Clin. Invest. 2004, 113:946-951.
8. de la C Sierra B., Kouri G., Guzman M. Race: a risk factor for dengue hemorrhagic fever. Arch. Virol. 2006, 152:533-542.
9. Fink J., Gu F., Ling L., Tolfvenstam T., Olfat F., Chin K.C., et al. Host gene expression profiling of dengue virus infection in cell lines and patients. PLoS Negl. Trop. Dis. 2007, 1(2):e86.
10. Hsieh M.-F., Lai S.-L., Chen J.-P., Sung J.-M., Lin Y.-L., Wu-Hsieh B.A., et al. Both CXCR3 and CXCL10/IFN-Inducible protein 10 are required for resistance to primary infection by dengue virus. J. Immunol. 2006, 177:1855-1863.
11. Zeremski M., Dimova R., Brown Q., Jacobson I.M., Markatou M., Talal A.H. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection. J. Infect. Dis. 2009, 200:1774-1780.
12. Zhang B., Chan Y.K., Lu Bao, Diamond M.S., Klein R.S. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 2008, 180:2641-2649.
13. Clinical Practice Guideline: Management of Dengue Infection in Adult 2008, Ministry of Health, second ed., Malaysia.
14. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
15. Zakaria Z., Umi S.H., Mokhtar S.S., Mokhtar U., Zaiharina M.Z., Aziz A.T.A., et al. An alternate method for DNA and RNA extraction from clotted blood. Genet. Mol. Res. 2013, 12:302-311.
16. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., et al. The structure of haplotype blocks in the human genome. Science 2002, 298:2381-2385.
17. National Centre for Biotechnology Information. http://www.ncbi.nlm.nih.gov/variation/tools/1000genomes/.
18. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lweis I., et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 1996, 184:963-969.
19. Cole K.E., Strick C.A., Paradis T.J., Ogborne K.T., Loetscher M., Gladue R.P., et al. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 1998, 187:2009-2021.
20. Lahrtz F., Piali L., Nadal D., Pfister H.W., Spanaus K.S., et al. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 1997, 27:2484-2489.
21. Korniejewska A., McKnight A.J., Johnson Z., Watson M.L., Ward S.G. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. Immunology 2011, 132:503-515.
22. Qin S.X., Rottman J.B., Myers P., Kassam N., Weinblatt M., Loetscher M., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998, 101:746-754.
23. Mach F., Sauty A., Iarossi A.S., Sukhova G.K., Neote K., Libby P., et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J. Clin. Invest. 1999, 104:1041-1050.
24. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 1999, 103:807-815.
25. Chen J.-P., Lu H.-L., Lai S.-L., Campanella G.S., Sung J.-M., Lu M.-Y., et al. Dengue virus induces expression of CXC chemokine ligand 10/IFN-γ-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J. Immunol. 2006, 177:3185-3192.
26. Ip P.P., Liao F. Resistance to dengue virus infection in mice is potentiated by CXCL10 and is independent of CXCL10-mediated leukocyte recruitment. J. Immunol. 2010, 184:5705-5714.
27. Wong K.L., Chen W., Balakrishnan T., Toh Y.X., Fink K., Wong S.-C. Susceptibility and response of human blood monocyte subsets to primary dengue virus infection. PLoS One 2012, 7(5):e36435.
28. Shanmugam N., Ransohoff R.M., Natarajan R. Interferon-gamma-inducible protein (IP)-10 mRNA stabilized by RNA-binding proteins in monocytes treated with S100b. J. Biol. Chem. 2006, 281:31212-31221.
29. Klich I., Fendler W., Wyka K., Młynarski W. Effect of the IP10 (CXCL10) and HLA genotype on the risk of type 1 diabetes in children. Pediatr. Endocrinol. Diabetes Metab. 2011, 17:10-13.
30. Ng M.W., Zhou G., Chong W.P., Lee L.W.Y., Law H.K.W., Zhang H., et al. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect. Dis. 2007, 7:50.
31. Database for Short Genetic Variation. http://www.ncbi.nlm.nih.gov/projects/SNP/.
32. FastSNP. http://fastsnp.ibms.sinica.edu.tw/pages/input_CandidateGeneSearch.jsp.
33. Helbig K.J., Ruszkiewicz A., Semendric L., Harley H.A., McColl S.R., Beard M.R. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology 2004, 39:1220-1229.
34. Zhao H., Pfeiffer R., Gail M.H. Haplotype analysis in population genetics and association studies. Pharmacogenomics 2003, 2003(4):171-178.